CareDx (CDNA)
(Real Time Quote from BATS)
$14.47 USD
+0.17 (1.19%)
Updated Sep 18, 2025 11:52 AM ET
4-Sell of 5 4
B Value B Growth F Momentum B VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
CDNA 14.47 +0.17(1.19%)
Will CDNA be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for CDNA based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for CDNA
Do Options Traders Know Something About CareDx Stock We Don't?
Here's What Key Metrics Tell Us About CareDx (CDNA) Q2 Earnings
CDNA: What are Zacks experts saying now?
Zacks Private Portfolio Services
CareDx (CDNA) Lags Q2 Earnings and Revenue Estimates
CareDx (CDNA) Surges 7.0%: Is This an Indication of Further Gains?
CareDx (CDNA) Tops Q1 Earnings Estimates
Other News for CDNA
Is CDNA showing downside potential? Shooting Star Candlestick shows up after climbing 0.85%
50 Day Moving Average Support appears for CDNA after 1.14% move
CareDx management to meet with BTIG
Is CDNA likely to continue higher? Crossed Above 50 Day Moving Average shows up after gaining 3.62%
CareDx management to meet with BTIG